Skip to content

The impact of magnesium sulfate on early postoperative cognitive dysfunction in elderly patients undergoing laparoscopic colorectal cancer surgery: A double-blind, placebo-controlled, randomized controlled trial

The impact of magnesium sulfate on early postoperative cognitive dysfunction in elderly patients undergoing laparoscopic colorectal cancer surgery: A double-blind, placebo-controlled, randomized controlled trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092987
Enrollment
Unknown
Registered
2024-11-26
Start date
2024-11-30
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Cognitive Dysfunction

Interventions

Magnesium sulfate group:Intraoperative infusion of magnesium sulfate
Control group:Intraoperative infusion of saline

Sponsors

the Affiliated Hospital of Jiangnan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Classified as ASA II to III according to the American Society of Anesthesiologists (ASA) physical status classification 2.Preoperative Montreal Cognitive Assessment (MoCA) score = 26 and Mini-Mental State Examination (MMSE) score > 23." 3.Planned to undergo laparoscopic colon cancer surgery with general anesthesia and endotracheal intubation 4.The expected duration of the surgery is at least 2 hours.

Exclusion criteria

Exclusion criteria: 1. Significant neurological and psychiatric disorders 2. Renal impairment (serum creatinine > 177 µmol/L) or active liver disease. 3. Recent use of sedative-hypnotics, analgesics, and antidepressants 4. History of drug and alcohol abuse 5. Severe visual and hearing impairments affecting communication 6. Preoperative infection, recent use of corticosteroids or other immunosuppressants 7. Contraindications for the use of magnesium sulfate 8. Transfusion of more than 3 units of red blood cells during the perioperative period 9. Unable to understand or cooperate in completing the assessment

Design outcomes

Primary

MeasureTime frame
Incidence of Post-Operative Cognitive Dysfunction;

Secondary

MeasureTime frame
Consumption of anesthetic agents;Extubation time;Postoperative pain;Postoperative Nausea and Vomiting;Dynamic heart rate changes;Dynamic blood pressure changes.;

Countries

China

Contacts

Public ContactGuangling Li

Affiliated Hospital of Jiangnan University

lgl007@126.com+86 158 6159 1083

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026